about
Characterization of cultured cholangiocytes isolated from livers of patients with primary sclerosing cholangitisAdvances in Biliary Tract Disorders: Novel Biomarkers, Pharmacotherapies, Endoscopic Techniques, and Surgical Management.Cholangiohepatitis With Extensive Intrahepatic Choledocholithiasis.Surveillance for Hepatobiliary Cancers in Patients with Primary Sclerosing Cholangitis.Complications, symptoms, quality of life and pregnancy in cholestatic liver disease.Endoluminal stenting via the suture-assisted flange engagement technique.Over-the-wire technique to facilitate over-the-scope clip closure of fistulae.Update on pharmacotherapies for cholestatic liver disease.Hemobilia: Perspective and Role of the Advanced EndoscopistMetabolomic Profiling of Portal Blood and Bile Reveals Metabolic Signatures of Primary Sclerosing CholangitisAnastomotic Biliary Stricture Development after Liver Transplantation in the Setting of Retained Prophylactic Intraductal Pediatric Feeding Tube: Case and ReviewAdvances in Therapeutic EndoscopyEditorial: is proton pump inhibitor use associated with worse outcomes in patients with liver abscesses?Distinguishing immunoglobulin G4-related disease from its pancreatobiliary mimics: Are we there now?Dominant strictures in primary sclerosing cholangitis: A multicenter survey of clinical definitions and practicesNGM282, an FGF19 analogue, in primary sclerosing cholangitis: A nebulous matterMachine Learning-based Development and Validation of a Scoring System for Screening High-Risk Esophageal VaricesHemobilia: Historical overview, clinical update, and current practicesSignet Ring Cell Gastric Carcinoma: Clinical Epidemiology and Outcomes in a Predominantly Latino County Hospital Population
P50
Q34287861-4D6F958E-15EB-4F0E-BCED-2AFD1F2AE89FQ40451522-660075DE-7237-4110-93DB-31E7669BCEBFQ46260713-80F5C282-540A-43A2-B911-564231820E20Q48110598-679F5525-4D44-4B26-B205-BE8D61D4CD33Q48331749-A6CAB929-8893-4EDD-8866-7209EAB10438Q51810315-013E3DB9-8B19-4302-A50F-92F5E1830D74Q54640032-B30F9359-8B03-4913-8032-CB4F63B92504Q55333522-A24BAD1F-2692-41E7-A18C-8B037DCE9E3BQ57114984-11F00482-1986-4D33-A485-75D7102ABEDDQ58555748-1E044500-56A6-49DB-AF11-D259005A1E47Q58603984-6588A47F-506E-4377-B61A-9C95B117A7C5Q64102988-1EF11D00-FE6C-44A5-B51B-8FDC6A3EDDFAQ88161355-3974A8A6-DE99-4106-9964-EAB6368837B4Q89307098-25D6CF47-0C8F-4E3D-AEF3-9BC434F9CF8BQ90354788-0316F636-893F-4F39-98AA-9114FCF430B8Q90968654-98357AED-D7F5-4D6B-898B-91878EEFCDB3Q91305964-9CDD6D9F-C537-4F3A-AA8B-3F4E155F7EE9Q92740646-1D3F87ED-46C8-496E-854E-72DEB40F8D38Q95655205-EB6674F7-6BE4-4FCB-945D-E19A096F2CD3
P50
description
researcher ORCID ID = 0000-0001-9104-1702
@en
wetenschapper
@nl
name
James H Tabibian
@ast
James H Tabibian
@en
James H Tabibian
@nl
type
label
James H Tabibian
@ast
James H Tabibian
@en
James H Tabibian
@nl
prefLabel
James H Tabibian
@ast
James H Tabibian
@en
James H Tabibian
@nl
P31
P496
0000-0001-9104-1702